AT1 trading on a high the last two days due to NSW Govt public health response adopting the use of antigen testing for COVID 19. Investors speculating that this will translate into a material increase in sales of their Rapid Antigen Testing Kit (developed by Access Bio and on-sold in Australia under the Atomo brand).
Waiting patiently for a Q4 update from LDX tomorrow, and even more patiently for the FDA approval of Febridx (god knows when)!
LDX Price at posting:
$1.14 Sentiment: Hold Disclosure: Held
